Aktiengesellschaft Bayer's Net Worth

$2.33 Billion

Estimate Recalculated Jun 24, 2024 04:36PM EST

Who is Aktiengesellschaft Bayer?

Aktiengesellschaft Bayer has an estimated net worth of $2.33 Billion. This is based on reported shares across multiple companies, which include Azitra Inc, Elanco Animal Health Inc, Century Therapeutics, Inc., CRISPR Therapeutics AG, Pyxis Oncology, Inc., and Senti Biosciences, Inc..

SEC CIK

Aktiengesellschaft Bayer's CIK is 0001144145

Past Insider Trading and Trends

2021 was Aktiengesellschaft Bayer's most active year for acquiring shares with 4 total transactions. Aktiengesellschaft Bayer's most active month to acquire stocks was the month of May. 2021 was Aktiengesellschaft Bayer's most active year for disposing of shares, totalling 4 transactions. Aktiengesellschaft Bayer's most active month to dispose stocks was the month of May. 2021 saw Aktiengesellschaft Bayer paying a total of $15,000,000.00 for 15,418,176 shares, this is the most they've acquired in one year. In 2020 Aktiengesellschaft Bayer cashed out on 54,500,000 shares for a total of $1,626,367,200.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Azitra Inc (AZTR) Snapshot price: $0.9601

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.31M
—
—
1.31M
Jun 21
Form 3
—
0
—
—
0
No matching records found

Elanco Animal Health Inc (ELAN) Snapshot price: $15.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-74.71%
-54.50M
$29.84
-$1,626,367,200.00
18.45M
Dec 3
Form 3
—
0
—
—
0
No matching records found

Century Therapeutics, Inc. (IPSC) Snapshot price: $4.56

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
12.68M
$20.00
—
12.68M
Jun 22
Form 3
—
0
—
—
0
No matching records found

CRISPR Therapeutics AG (CRSP) Snapshot price: $65.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.33%
527.47K
$22.75
$11,999,988.00
5.63M
Jan 5
Form 3
—
0
—
—
0
No matching records found

Pyxis Oncology, Inc. (PYXS) Snapshot price: $3.71

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.74M
—
—
2.74M
Oct 13
Form 3
—
0
—
—
0
No matching records found